Camp4 Therapeutics Corporation

US$4.06As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CAMPHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (37.90%)
Div yield —
ROE (146.12%)
Biotechnology
Beta (5Y) 0.28
PE TTM —
TSR TTM (2.40%)
Mkt cap US$254.8M
ROIC (36.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.39
8.07%
(36.55%)
Hold 4|6|3|11|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.09
0.08
32.36%
35.20%
30.91%
24.09%
Revenue$M
18.49
19.52
19.70
19.38
5.65%
6.92%
6.11%
3.87%
Peers (US$254.8M)
Cap (US$)
PE
259.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.955
1.172
0.790
EBIT/Intx
1.080
0.111
0.113
Own earn%
(81.32)
8.60
27.69
Sh yield%
47.16
20.37
20.73
Owners
Insiders/Inst%
14.03
81.62
Short interest%
3.86
SBC / revenue%
0.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
29–36
$1 testx
0.0
Incr. ROIC%
5